These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1816112)

  • 21. Molecular confirmation of Bacillus Calmette Guerin vaccine related adverse events among Saudi Arabian children.
    Al-Hajoj S; Memish Z; Abuljadayel N; AlHakeem R; AlRabiah F; Varghese B
    PLoS One; 2014; 9(11):e113472. PubMed ID: 25409184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymph node swelling due to bacille Calmette-Guérin vaccination with multipuncture method.
    Mori T; Yamauchi Y; Shiozawa K
    Tuber Lung Dis; 1996 Jun; 77(3):269-73. PubMed ID: 8758112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of lymphadenitis following BCG vaccination.
    Ungthavorn P; Su-amphan A
    J Med Assoc Thai; 1978 May; 61(5):256-9. PubMed ID: 650120
    [No Abstract]   [Full Text] [Related]  

  • 24. Splitting the dose of neonatal BCG vaccination: a naïve practice.
    Fretzayas A; Moustaki M; Stefos E; Nicolaidou P
    Ann Trop Paediatr; 2009 Sep; 29(3):243-5. PubMed ID: 19689870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating clinical course of BCG lymphadenitis and factors affect on it during a 5-year period in Kerman, Iran.
    Daei Parizi M; Kardoust Parizi A; Izadipour S
    J Trop Pediatr; 2014 Apr; 60(2):148-53. PubMed ID: 24327454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BCG lymphadenitis: a report of eight cases.
    Abdullah MA; Adam KA; Shagla A; Mahgoub S
    Ann Trop Paediatr; 1985 Jun; 5(2):77-81. PubMed ID: 2409910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigations into an outbreak of suppurative lymphadenitis with BCG vaccine SSI(®) in Singapore.
    Soh SB; Han PY; Tam KT; Yung CF; Liew WK; Tan NW; Chong CY; Thoon KC
    Vaccine; 2014 Oct; 32(44):5809-15. PubMed ID: 25173482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of post-BCG lymphadenitis.
    Bhandari B; Khurana R; Mandowara SL
    Indian J Pediatr; 1980; 47(388):367-70. PubMed ID: 7228236
    [No Abstract]   [Full Text] [Related]  

  • 29. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae.
    Gupte MD; Anantharaman DS; De Britto RL; Vallishayee RS; Nagaraju B; Kannan S; Sengupta U
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of lymphadenitis following Bacillus Calmette-Guérin (BCG) vaccination in north Indian children.
    Rangesh S; Vaidya PC; Mehra N; Gupta S; Bharti B
    Indian J Tuberc; 2022 Oct; 69(4):596-601. PubMed ID: 36460395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caseating regional lymphadenitis complicating BCG vaccination: a report of 6 cases.
    Tam PK; Stroebel AB; Saing H; Lau JT; Ong GB
    Arch Dis Child; 1982 Dec; 57(12):952-4. PubMed ID: 7181528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacillus Calmette-Guerin (BCG) lymphadenitis-changing trends and management.
    Nazir Z; Qazi SH
    J Ayub Med Coll Abbottabad; 2005; 17(4):16-8. PubMed ID: 16599027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potency and suppurative adenitis in BCG vaccination.
    Gheorghiu M; Carnus H; Lagrange P; Chambon L
    Dev Biol Stand; 1978; 41():79-84. PubMed ID: 381076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of oral cephalexin in the treatment of BCG lymphadenitis.
    Ayazi P; Mahyar A; Taremiha A; Ghorani N; Esmailzadehha N
    Infez Med; 2014 Jun; 22(2):112-7. PubMed ID: 24955797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current problems of BCG innoculation of newborns and children].
    Habedank M
    Z Geburtshilfe Perinatol; 1979 Dec; 183(6):393-5. PubMed ID: 398103
    [No Abstract]   [Full Text] [Related]  

  • 36. [Adverse event after BCG vaccination in Poland in the years 1994-1997].
    Szczuka I
    Pneumonol Alergol Pol; 1999; 67(5-6):208-16. PubMed ID: 10570642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increase in Lymphadenitis Cases after Shift in BCG Vaccine Strain.
    Kuchukhidze G; Kasradze A; Dolakidze T; Baliashvili D; Merabishvili T; Blumberg HM; Kempker RR
    Emerg Infect Dis; 2015 Sep; 21(9):1677-9. PubMed ID: 26291303
    [No Abstract]   [Full Text] [Related]  

  • 38. BCG vaccination of neonates, infants, schoolchildren and adolescents. Part II: Safety of a vaccine with strain 1331 Copenhagen.
    Lehmann HG; Engelhardt H; Freudenstein H; Hennessen W; Quast U; Widmark RM
    Dev Biol Stand; 1979; 43():133-6. PubMed ID: 520665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe axillary lymphadenitis after BCG vaccination: alert for primary immunodeficiencies.
    Santos A; Dias A; Cordeiro A; Cordinhã C; Lemos S; Rocha G; Faria E
    J Microbiol Immunol Infect; 2010 Dec; 43(6):530-7. PubMed ID: 21195982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Needle aspiration for suppurative post-BCG adenitis.
    Banani SA; Alborzi A
    Arch Dis Child; 1994 Nov; 71(5):446-7. PubMed ID: 7826118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.